Amelioration of lupus nephritis by serum amyloid P component gene therapy with distinct mechanisms varied from different stage of the disease

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Zhang, Weijuan ^a   Wu, Jin ^a   Qiao, Bin ^a   Xu, Wei ^a   Xiong, Sidong ^a,b  

^a FUDAN UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CELL DNA; COMPLEMENTARY DNA; DOUBLE STRANDED DNA ANTIBODY; PLASMID DNA; SERUM AMYLOID P; ANTINUCLEAR ANTIBODY; BIOLOGICAL MARKER; DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; DRUG EFFECT; DRUG PURIFICATION; FEMALE; GENE THERAPY; IMMUNOREGULATION; IN VITRO STUDY; INNATE IMMUNITY; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEINURIA; TREATMENT RESPONSE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; GENETICS; IMMUNOLOGY; INFLAMMATION; LEUKOCYTE; LYMPHOCYTE ACTIVATION; METABOLISM; METHODOLOGY; PLASMID;

MUS;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIGEN-ANTIBODY COMPLEX; BIOLOGICAL MARKERS; DNA; FEMALE; GENE THERAPY; IMMUNITY, INNATE; INFLAMMATION; LEUKOCYTES; LUPUS NEPHRITIS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; PLASMIDS; SERUM AMYLOID P-COMPONENT;

EID: 79960733930     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022659     Document Type: Article

References (40)

1. Rahman A, Isenberg DA, (2008) Systemic lupus erythematosus. N Engl J Med 358: 929-939.
2. Walport MJ, (2000) Lupus, DNase and defective disposal of cellular debris. Nat Genet 25: 135-136.
3. Kotzin BL, (1996) Systemic lupus erythematosus. Cell 85: 303-306.
4. Savill J, Dransfield I, Gregory C, Haslett C, (2002) A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2: 965-975.
5. Hoffmann MH, Trembleau S, Muller S, Steiner G, (2010) Nucleic acid-associated autoantigens: pathogenic involvement and therapeutic potential. J Autoimmun 34: J178-206.
6. Qiao B, Wu J, Chu YW, Wang Y, Wang DP, et al. (2005) Induction of systemic lupus erythematosus-like syndrome in syngeneic mice by immunization with activated lymphocyte-derived DNA. Rheumatology (Oxford) 44: 1108-1114.
7. Wen ZK, Xu W, Xu L, Cao QH, Wang Y, et al. (2007) DNA hypomethylation is crucial for apoptotic DNA to induce systemic lupus erythematosus-like autoimmune disease in SLE-non-susceptible mice. Rheumatology (Oxford) 46: 1796-1803.
8. Zhang W, Xu W, Xiong S, (2010) Blockade of Notch1 signaling alleviates murine lupus via blunting macrophage activation and M2b polarization. J Immunol 184: 6465-6478.
9. Garlanda C, Bottazzi B, Bastone A, Mantovani A, (2005) Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 23: 337-366.
10. Bottazzi B, Doni A, Garlanda C, Mantovani A, (2010) An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu Rev Immunol 28: 157-183.
11. Lu J, Marnell LL, Marjon KD, Mold C, Du Clos TW, et al. (2008) Structural recognition and functional activation of FcgammaR by innate pentraxins. Nature 456: 989-992.
12. Mold C, Gresham HD, Du Clos TW, (2001) Serum amyloid P component and C-reactive protein mediate phagocytosis through murine Fc gamma Rs. J Immunol 166: 1200-1205.
13. Pepys MB, Butler PJ, (1987) Serum amyloid P component is the major calcium-dependent specific DNA binding protein of the serum. Biochem Biophys Res Commun 148: 308-313.
14. Breathnach SM, Kofler H, Sepp N, Ashworth J, Woodrow D, et al. (1989) Serum amyloid P component binds to cell nuclei in vitro and to in vivo deposits of extracellular chromatin in systemic lupus erythematosus. J Exp Med 170: 1433-1438.
15. Bickerstaff MC, Botto M, Hutchinson WL, Herbert J, Tennent GA, et al. (1999) Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat Med 5: 694-697.
16. Bharadwaj D, Mold C, Markham E, Du Clos TW, (2001) Serum amyloid P component binds to Fc gamma receptors and opsonizes particles for phagocytosis. J Immunol 166: 6735-6741.
17. Triantafyllopoulou A, Franzke CW, Seshan SV, Perino G, Kalliolias GD, et al. (2010) Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages. Proc Natl Acad Sci USA 107: 3012-3017.
18. Schiffer L, Bethunaickan R, Ramanujam M, Huang W, Schiffer M, et al. (2008) Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis. J Immunol 180: 1938-1947.
19. Hale MB, Krutzik PO, Samra SS, Crane JM, Nolan GP, (2009) Stage dependent aberrant regulation of cytokine-STAT signaling in murine systemic lupus erythematosus. PLoS One 4: e6756.
20. Bygrave AE, Rose KL, Cortes-Hernandez J, Warren J, Rigby RJ, et al. (2004) Spontaneous autoimmunity in 129 and C57BL/6 mice-implications for autoimmunity described in gene-targeted mice. PLoS Biol 2: E243.
21. Gillmore JD, Hutchinson WL, Herbert J, Bybee A, Mitchell DA, et al. (2004) Autoimmunity and glomerulonephritis in mice with targeted deletion of the serum amyloid P component gene: SAP deficiency or strain combination? Immunology 112: 255-264.
22. Tamaoki T, Tezuka H, Okada Y, Ito S, Shimura H, et al. (2005) Avoiding the effect of linked genes is crucial to elucidate the role of Apcs in autoimmunity. Nat Med 11: 11-12; author reply 12-13.
23. Napirei M, Karsunky H, Zevnik B, Stephan H, Mannherz HG, et al. (2000) Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet 25: 177-181.
24. Zykova SN, Tveita AA, Rekvig OP, (2010) Renal Dnase1 enzyme activity and protein expression is selectively shut down in murine and human membranoproliferative lupus nephritis. PLoS One 5: e12096.
25. Murray LA, Rosada R, Moreira AP, Joshi A, Kramer MS, et al. (2010) Serum amyloid P therapeutically attenuates murine bleomycin-induced pulmonary fibrosis via its effects on macrophages. PLoS One 5: e9683.
26. Fenton K, Fismen S, Hedberg A, Seredkina N, Fenton C, et al. (2009) Anti-dsDNA antibodies promote initiation, and acquired loss of renal Dnase1 promotes progression of lupus nephritis in autoimmune (NZBxNZW)F1 mice. PLoS One 4: e8474.
27. Emsley J, White HE, O'Hara BP, Oliva G, Srinivasan N, et al. (1994) Structure of pentameric human serum amyloid P component. Nature 367: 338-345.
28. Sorensen IJ, Holm Nielsen E, Schroder L, Voss A, Horvath L, et al. (2000) Complexes of serum amyloid P component and DNA in serum from healthy individuals and systemic lupus erythematosus patients. J Clin Immunol 20: 408-415.
29. Muehrcke RC, Kark RM, Pirani CL, Pollak VE, (1957) Lupus nephritis: a clinical and pathologic study based on renal biopsies. Medicine (Baltimore) 36: 1-145.
30. Kuroiwa T, Lee EG, (1998) Cellular interactions in the pathogenesis of lupus nephritis: the role of T cells and macrophages in the amplification of the inflammatory process in the kidney. Lupus 7: 597-603.
31. Andrews BS, Eisenberg RA, Theofilopoulos AN, Izui S, Wilson CB, et al. (1978) Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med 148: 1198-1215.
32. Ito T, Schaller M, Hogaboam CM, Standiford TJ, Sandor M, et al. (2009) TLR9 regulates the mycobacteria-elicited pulmonary granulomatous immune response in mice through DC-derived Notch ligand delta-like 4. J Clin Invest 119: 33-46.
33. Lake FR, Noble PW, Henson PM, Riches DW, (1994) Functional switching of macrophage responses to tumor necrosis factor-alpha (TNF alpha) by interferons. Implications for the pleiotropic activities of TNF alpha. J Clin Invest 93: 1661-1669.
34. Sheerin NS, Abe K, Risley P, Sacks SH, (2006) Accumulation of immune complexes in glomerular disease is independent of locally synthesized c3. J Am Soc Nephrol 17: 686-696.
35. Chintalacharuvu SR, Wang JX, Giaconia JM, Venkataraman C, (2005) An essential role for CCL3 in the development of collagen antibody-induced arthritis. Immunol Lett 100: 202-204.
36. Dupont KM, Sharma K, Stevens HY, Boerckel JD, Garcia AJ, et al. (2010) Human stem cell delivery for treatment of large segmental bone defects. Proc Natl Acad Sci U S A 107: 3305-3310.
37. Xu J, Yun X, Jiang J, Wei Y, Wu Y, et al. (2010) Hepatitis B virus X protein blunts senescence-like growth arrest of human hepatocellular carcinoma by reducing Notch1 cleavage. Hepatology 52: 142-154.
38. Estabrook MM, Jack DL, Klein NJ, Jarvis GA, (2004) Mannose-binding lectin binds to two major outer membrane proteins, opacity protein and porin, of Neisseria meningitidis. J Immunol 172: 3784-3792.
39. Chung EY, Liu J, Homma Y, Zhang Y, Brendolan A, et al. (2007) Interleukin-10 expression in macrophages during phagocytosis of apoptotic cells is mediated by homeodomain proteins Pbx1 and Prep-1. Immunity 27: 952-964.
40. Gao B, Duan Z, Xu W, Xiong S, (2009) Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain. Hepatology 50: 424-433.